ALGIPHARMA Trademark

Trademark Overview

On Monday, September 12, 2016, a trademark application was filed for ALGIPHARMA with the United States Patent and Trademark Office. The USPTO has given the ALGIPHARMA trademark a serial number of 79198826. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, June 14, 2024. This trademark is owned by AlgiPharma AS. The ALGIPHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation for the treatment and prevention of microbial biofilm infections, and to normalize stagnant and viscous mucus for the treatment of pulmonary diseases, namely, cystic fibrosis and COPD, medical preparations for the treatment of infected wounds and ulcers, and veterinary preparations for biofilm infections, namely, mastitis and wounds
algipharma

General Information

Serial Number79198826
Word MarkALGIPHARMA
Filing DateMonday, September 12, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, June 14, 2024
Registration Number5343262
Registration DateTuesday, November 28, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 12, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparation for the treatment and prevention of microbial biofilm infections, and to normalize stagnant and viscous mucus for the treatment of pulmonary diseases, namely, cystic fibrosis and COPD, medical preparations for the treatment of infected wounds and ulcers, and veterinary preparations for biofilm infections, namely, mastitis and wounds

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 14, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAlgiPharma AS
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressN-1337 Sandvika
NO
Party NameAlgiPharma AS
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressN-1337 Sandvika
NO
Party NameAlgiPharma AS
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressN-1337 Sandvika
NO

Trademark Events

Event DateEvent Description
Tuesday, December 27, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 22, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, December 27, 2016ASSIGNED TO EXAMINER
Saturday, December 31, 2016APPLICATION FILING RECEIPT MAILED
Wednesday, January 4, 2017NON-FINAL ACTION WRITTEN
Thursday, January 5, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, January 13, 2017REFUSAL PROCESSED BY MPU
Friday, January 13, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, February 3, 2017REFUSAL PROCESSED BY IB
Wednesday, July 12, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 12, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 12, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 3, 2017EXAMINER'S AMENDMENT ENTERED
Thursday, March 15, 2018FINAL DISPOSITION PROCESSED
Thursday, August 3, 2017EXAMINERS AMENDMENT -WRITTEN
Thursday, August 3, 2017ASSIGNED TO LIE
Friday, August 4, 2017EXAMINERS AMENDMENT MAILED
Wednesday, August 9, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 23, 2017NOTICE OF PUBLICATION
Tuesday, September 12, 2017PUBLISHED FOR OPPOSITION
Tuesday, November 28, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, February 28, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, June 14, 2024CANCELLED SECTION 71
Wednesday, April 30, 2025INVALIDATION PROCESSED
Saturday, May 17, 2025TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, April 30, 2025TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, March 15, 2018FINAL DISPOSITION NOTICE SENT TO IB
Friday, May 4, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, February 14, 2025TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, March 7, 2025NEW REPRESENTATIVE AT IB RECEIVED

Related Keywords

algipharma treatment wounds preparations biofilm namely infections copd fibrosis mastitis medical